Exact Mass: 293.0543
Exact Mass Matches: 293.0543
Found 243 metabolites which its exact mass value is equals to given mass value 293.0543,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
typhon
CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9257; ORIGINAL_PRECURSOR_SCAN_NO 9255 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9197; ORIGINAL_PRECURSOR_SCAN_NO 9195 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9205; ORIGINAL_PRECURSOR_SCAN_NO 9203 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9250; ORIGINAL_PRECURSOR_SCAN_NO 9246 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4784; ORIGINAL_PRECURSOR_SCAN_NO 4780 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4767; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4773; ORIGINAL_PRECURSOR_SCAN_NO 4771 ORIGINAL_ACQUISITION_NO 4761; CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 4756 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9251; ORIGINAL_PRECURSOR_SCAN_NO 9247 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9148; ORIGINAL_PRECURSOR_SCAN_NO 9147 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4768; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4761; ORIGINAL_PRECURSOR_SCAN_NO 4756 CONFIDENCE standard compound; INTERNAL_ID 553; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4740; ORIGINAL_PRECURSOR_SCAN_NO 4739 KEIO_ID T112; [MS2] KO009258 KEIO_ID T112; [MS3] KO009259 KEIO_ID T112; [MS3] KO009260 D016573 - Agrochemicals D010575 - Pesticides KEIO_ID T112
[(2R,3S,4R,5R)-3,4-dihydroxy-5-pyrimidin-1-ium-1-yl-tetrahydrofuran-2-yl]methyl dihydrogen phosphate
S-(Indolylmethylthiohydroximoyl)-L-cysteine
Lumiracoxib
Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug. On August 11, 2007, Australias Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver failure. New Zealand and Canada have also followed suit in recalling the drug. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
N-(2-hydroxymethyl-3-chloro-4-hydroxyphenyl)anthranilic acid
N-(2-hydroxymethyl-3-chloro-4-hydroxyphenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.
Islatravir
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors
N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
N'-[(4-Oxo-4H-chromen-3-yl)methylene]nicotinohydrazide
3G8CFM4T9A
Aristololactam is a natural product found in Aristolochia tubiflora, Aristolochia argentina, and other organisms with data available. Aristololactam I (AL-I), is the main metabolite of aristolochic acid I (AA-I), participates in the processes that lead to renal damage. Aristololactam I (AL-I) directly injures renal proximal tubule cells, the cytotoxic potency of AL-I is higher than that of AA-I and that the cytotoxic effects of these molecules are mediated through the induction of apoptosis in a caspase-3-dependent pathway[1]. Aristololactam I (AL-I), is the main metabolite of aristolochic acid I (AA-I), participates in the processes that lead to renal damage. Aristololactam I (AL-I) directly injures renal proximal tubule cells, the cytotoxic potency of AL-I is higher than that of AA-I and that the cytotoxic effects of these molecules are mediated through the induction of apoptosis in a caspase-3-dependent pathway[1].
Noraristolodione
Noraristolodione is a natural product found in Aristolochia elegans, Aristolochia indica, and other organisms with data available.
2,2,2-Trichlor-1-(4-hydroxy-2-isopropyl-5-methyl-phenyl)-aethanon-imin|2,2,2-trichloro-1-(4-hydroxy-2-isopropyl-5-methyl-phenyl)-ethanone-imine
Indolo[3,2,1-ij]quinolino[4,5-bc][1,5]naphthyridine
6-chloro-n-(2-chlorophenyl)-1-methyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine
TRIADIMEFON
D016573 - Agrochemicals D010575 - Pesticides
Lumiracoxib
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
5-chloro-2-hydroxy-3-nitro-[1,1-Biphenyl]-3-carboxylic acid
2-AMINO-4-(3,4-DIMETHOXYPHENYL)THIOPHENE-3-CARBOXYLICACIDMETHYLESTER
Benserazide hydrochloride
C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C471 - Enzyme Inhibitor
methyl 4-(4-chlorophenyl)imino-5,5,5-trifluoropentanoate
5-tert-butoxycarbonylamino-benzo[b]thiophene-2-carboxylic acid
ETHYL 2-(3,4-DIMETHOXYPHENYL)THIAZOLE-4-CARBOXYLATE
[3-Acetyl-2-(4-fluoro-phenyl)-4-hydroxy-5-oxo-2,5-dihydro-pyrrol-1-yl]-acetic acid
8,9-difluoro-5-methyl-1,7-dioxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic acid
Benzenesulfonic acid,4-methyl-, 4-nitrophenyl ester
4-(3-(Trifluoromethyl)benzoyl)-piperidine hydrochloride
METHYL 5-(TERT-BUTYL)-1-(6-CHLOROPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBOXYLATE
5-Bromo-1-(4-methoxybenzyl)-1H-pyrrole-2-carbaldehyde
ethyl 2-[2-(4-fluorophenyl)-2-oxoethyl]-1,3-thiazole-4-carboxylate
Benzonitrile, 2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-4-fluoro
Meclofenoxate hydrochloride
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D020011 - Protective Agents Meclofenoxate hydrochloride is an ester synthesized from DMAE and pCPA, which has the activity of stimulating memory and improving cognition.
1-(5-(TERT-BUTYL)ISOXAZOL-3-YL)-3-(4-CHLOROPHENYL)UREA
1-(5-(TERT-BUTYL)ISOXAZOL-3-YL)-3-(3-CHLOROPHENYL)UREA
3-(4-NITRO-PHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE
6-chloro-2-(2-cyclopentylethyl)imidazo[1,2-b]pyridazine-3-carboxylic acid
N-(4-methylphenyl)sulfonylbenzenecarboximidoyl chloride
5,7-dichloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine
3,5-DI(THIOPHEN-2-YL)-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOTHIOAMIDE
2-(4-BROMO-PHENYL)-5-TERT-BUTYL-2H-PYRAZOL-3-YLAMINE
2-(3-BROMO-PHENYL)-5-TERT-BUTYL-2H-PYRAZOL-3-YLAMINE
6-Benzyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine
2-(3-METHOXYPHENYL)PYRIDO[3,2:4,5]FURO[3,2-D]PYRIMIDIN-4(3H)-ONE
4-BROMO-1,3-DIMETHYL-SPIRO[FURAN-2(5H),3-[3H]INDOL]-2(1H)-ONE
7-Benzyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyriMidine
2-AMINO-1-(2,6-DICHLOROBENZYL)-4,5-DIMETHYL-1H-PYRROLE-3-CARBONITRILE
2-CHLORO-N-[(4-CHLOROPHENYL)(PHENYL)METHYL]ACETAMIDE
Ethyl 5-chloro-3-(4-methoxyphenyl)-1,2,4-triazine-6-carboxylate
2-Bromo-N-methyl-1-adamantanemethanamine hydrochloride
Piperidin-4-yl (2-(trifluoromethyl)phenyl)methanone hydrochloride
(3,4-Dichlorophenyl)(piperidin-4-yl)methanone hydrochloride
5-amino-1,2,3-thiadiazole-n-phenoxycarbonyl-4-carboxylic acid ethyl ester
1-Benzyl-4-bromo-3-methyl-1H-pyrazole-5-carboxamide
(S)-3-BENZYLOXYCARBONYL-5-OXO-4-OXAZOLIDINEPROPANOIC ACID
2-CHLORO-N-(4-METHOXYBENZYL)-3-NITROPYRIDIN-4-AMINE
(2E)-3-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylacryla mide
5(4H)-Oxazolone,4-(1,3-benzodioxol-5-ylmethylene)-2-phenyl-
methyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride
N-(4-Chlorobenzylidene)-4-methylbenzenesulfonamide
1-[3,5-Bis(trifluoromethyl)phenyl]ethanamine Hydrochloride
ethyl 3-(2-carboxy-vinyl)-5-chloro-1h-indole-2-carboxylate
4-(2,4-dichlorophenoxy)butyric acid, compound with dimethylamine (1:1)
(4S)-2-[2-(Trifluoromethoxy)phenyl]-1,3-thiazolidine-4-carboxylic acid
(R)-Methyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride
MK-8591
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
(3-((3-CHLORO-4-FLUOROPHENYL)CARBAMOYL)PHENYL)BORONIC ACID
1-[4-(Trifluoromethyl)pyrimidin-2-yl]piperidine-4-carbonyl chloride
ethyl 1-cyclopropyl-6,7-difluoro-4-oxoquinoline-3-carboxylate
ethyl 2-(4-amino-3-methoxyphenyl)-3,3,3-trifluoro-2-hydroxypropanoate
8-ETHOXYQUINOLINE-5-SULFONIC ACID SODIUM SALT HEMIHYDROATE
[2-(3-bromo-phenyl)-ethyl]-(4-fluoro-phenyl)-amine
5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine
(1S)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one
1-(2-Chlorophenyl)-2-(3,5-dimethyl-4-nitro-1-pyrazolyl)ethanone
2-Chloro-3-pyridinecarboxylic acid [2-(4-fluorophenyl)-2-oxoethyl] ester
3-(4-Azidobenzyl)-4-hydroxycoumarin
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
6-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
9-Amino-5-(2-aminopyrimidin-4-yl)pyrido[3,2:4,5]pyrrolo[1,2-c]pyrimidin-4-ol
4-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-1,7-dihydroxy-2,3,5-trioxabicyclo[2.2.2]oct-7-en-6-one
1-(4-Chlorophenoxy)-3,3-dimethyl-1-(triazol-2-yl)butan-2-one
(2R)-2-amino-3-[(E)-N-hydroxy-C-(1H-indol-3-ylmethyl)carbonimidoyl]sulfanylpropanoic acid
(E)-1-(L-cystein-S-yl)-N-hydroxy-2-(1H-indol-3-yl)ethan-1-imine
N,N-diethyl-4-[hydroxy(sulfanyl)phosphinothioyl]oxy-6-methylpyrimidin-2-amine
N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide
3-[5-Amino-3-(4-chlorophenyl)-1-pyrazolyl]propanoic acid ethyl ester
3,4-dichloro-N-[(E)-pyridin-2-ylmethylideneamino]benzamide
3-(4-Methylphenyl)sulfonyl-3-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid
(2R)-2-amino-3-[(Z)-N-hydroxy-C-(1H-indol-3-ylmethyl)carbonimidoyl]sulfanylpropanoic acid
2-Butanone, 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-, (1R)-
2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide
3-Amino-4-[(4-chlorophenyl)thio]benzoic acid methyl ester
1-Ethyl-3-[(5-nitro-2-oxo-3-indolyl)amino]thiourea
3-hydroxy-7-methyl-3-(4-morpholinyl)-5-nitro-1H-indol-2-one
3-(Phenylmethyl)-6-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
1-[4-(4-Chlorophenyl)thiazol-2-yl]-2-(pentan-3-ylidene)hydrazine
6-chloro-5,7-dimethyl-N-(thiophen-2-ylmethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine
N-[(4-chlorophenyl)methyl]-2-(2,4-dioxo-1H-pyrimidin-6-yl)acetamide
3-(4-Methylphenyl)-6-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
1-[2-(4-Morpholinyl)-2-oxoethyl]-2-pyrido[2,3-b][1,4]thiazinone
1-S-(N-hydroxypent-4-enimidoyl)-1-thio-beta-D-glucopyranose
trans-2-Hexenal oxime, o-[(pentafluorophenyl)methyl]-
N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
3-butenyldesulfoglucosinolate
A desulfoglucosinolic acid resulting from the formal condensation of the thiol group of N-hydroxypent-4-enethioamide with beta-D-glucopyranose.
5-chloro-10,12-dihydroxy-11-propyl-2-oxa-7-azatricyclo[7.4.0.0³,⁷]trideca-1(13),3,5,9,11-pentaen-8-one
(2s,3r,4s,4ar,11br)-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridine-2,3,4,6-tetrol
13-methyl-3,5,8-trioxa-13-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹⁴,¹⁹]icosa-1(12),2(6),7(11),9,14,16,18-heptaen-20-one
(2r,3r,5s,6s)-3,5-dihydroxy-2-(hydroxymethyl)-6-(1h-indol-3-yloxy)oxan-4-one
(2r)-2-amino-3-{[(1z)-1-(hydroxyimino)-2-(1h-indol-3-yl)ethyl]sulfanyl}propanoic acid
2-{[1-(hydroxyimino)pent-4-en-1-yl]sulfanyl}-6-(hydroxymethyl)oxane-3,4,5-triol
aristolactam iiia; me ether
{"Ingredient_id": "HBIN016777","Ingredient_name": "aristolactam iiia; me ether","Alias": "NA","Ingredient_formula": "C17H11NO4","Ingredient_Smile": "NA","Ingredient_weight": "293.27","OB_score": "NA","CAS_id": "81451-90-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6666","PubChem_id": "NA","DrugBank_id": "NA"}
